JPRN-jRCT2080221624未知2 期
An Open-label, Multi-center, Phase 2 Study of AMG 162 (denosumab) in Subjects with Giant Cell Tumor of Bone
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 10 人开始时间: 2011年10月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 12age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Subjects with surgically unsalvageable Giant Cell Tumor of Bone or with surgically salvageable Giant Cell Tumor of Bone whose planned surgical procedure resulting in severe morbidity
排除标准
- •Currently receiving other specific treatment for Giant Cell Tumor of Bone
研究者
相似试验
进行中（未招募）
不适用
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without Bevacizumab - 20050190Treatment of patients with stage IIIb/IV non-small cell lung cancerMedDRA version: 14.1Level: PTClassification code 10029522Term: Non-small cell lung cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10029521Term: Non-small cell lung cancer stage IIIBSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2005-005484-28-ITAmgen Inc.224
已完成
2 期
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumablungcancerNon Small Cell Lungcancer10029107NL-OMON31650Amgen19
进行中（未招募）
不适用
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabSubjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabMedDRA version: 9.1Level: LLTClassification code 10029522Term: Non-small cell lung cancer stage IVMedDRA version: 9.1Level: LLTClassification code 10029521Term: Non-small cell lung cancer stage IIIBEUCTR2005-005484-28-PLAmgen Inc.200
进行中（未招募）
1 期
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabSubjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabMedDRA version: 8.1 Level: LLT Classification code 10029521 Term: Non-small cell lung cancer stage IIIBMedDRA version: 9.1 Level: LLT Classification code 10029522 Term: Non-small cell lung cancer stage IVEUCTR2005-005484-28-GBAmgen Inc.224
进行中（未招募）
1 期
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabSubjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabMedDRA version: 8.1Level: LLTClassification code 10029521Term: Non-small cell lung cancer stage IIIBMedDRA version: 9.1Level: LLTClassification code 10029522Term: Non-small cell lung cancer stage IVEUCTR2005-005484-28-SKAmgen Inc.224